Boston Scientific said the U.S. District Court for the District of Massachusetts granted preliminary approval on January 8, 2025 to a proposed settlement of 2 shareholder derivative actions and demands for access to books and records.

1. 01

   Boston Scientific said the U.S. District Court for the District of Massachusetts granted preliminary approval on January 8, 2025 to a proposed settlement of 2 shareholder derivative actions and demands for access to books and records.

2. 02

   The company said the settled lawsuits relate to the previously disclosed recall and retirement of the LOTUS Edge™ Aortic Valve System.

3. 03

   Boston Scientific said the settlement was entered into on September 6, 2024 under a Stipulation of Settlement, subject to court approval, among plaintiffs Diane Nachbaur and Frank Tripson, Excavators Union Local 731 Pension Fund, the company as nominal defendant, and the individual defendants.

4. 04

   The company said the court has scheduled a hearing on March 25, 2025 at 2 p.m. Eastern Time to decide whether to grant final approval. It said it attached the Stipulation of Settlement and the Notice of Proposed Derivative Settlement to this 8-K, as required by the preliminary approval order.

Analysis scope · Filing body only (exhibits excluded)We analyzed the filing body only. The exhibits exceeded the length limit and were excluded, so figures, financial statements and presentation materials in them were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.